GGrantIndex
Sort

64,565 grants matching drug discovery

Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells

$5,311,300
David Manuel Valenzuela · Regeneron Pharmaceuticals, Inc. · U01 · FY2006 · HG

Scripps Translational Science Institute

$5,309,318
Eric Jeffrey Topol · Scripps Research Institute, The · UL1 · FY2016 · TR

A1: A Multi-Scale Open Knowledge Network for Biomedicine

$5,299,996
Sergio E Baranzini · University Of California-San Francisco · · FY2020 · TIP

Discovery of novel Henipavirus inhibitors

$5,291,771
Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2022 · AI

Virology Core

$5,289,678
Charles M. Rice · Hackensack University Medical Center · U19 · FY2022 · AI

Integrative genetics of behavior with high throughput technologies

$5,274,705
David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA

Stem Cell Translation Laboratory (SCTL)

$5,256,473
Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR

Center to develop therapeutic countermeasures to high-threat bacterial agents

$5,254,272
David S Perlin · Rbhs-New Jersey Medical School · U19 · FY2015 · AI

Collaborative Research: EPiQC: Enabling Practical-Scale Quantum Computation

$5,253,688
Frederic T Chong · University Of Chicago · · FY2018 · CSE

NDC for the Optical Control of Biological Function

$5,246,633
Ehud Isacoff · University Of California Berkeley · PN2 · FY2008 · EY

Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1

$5,242,970
Harry Bernard Greenberg · Stanford University · UL1 · FY2009 · RR

UAB Center for AIDS Research

$5,237,656
Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2015 · AI

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)

$5,216,957
Robert Daniel Toto · Ut Southwestern Medical Center · UL1 · FY2015 · TR

Cancer Center Support

$5,204,424
Ronald B Herberman · University Of Pittsburgh At Pittsburgh · P30 · FY2007 · CA

The Vanderbilt Specialized Chemistry Center for Accelerated Probe Development

$5,188,419
Craig Lindsley · Vanderbilt University · U54 · FY2011 · MH

Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells

$5,172,790
David Manuel Valenzuela · Regeneron Pharmaceuticals, Inc. · U01 · FY2008 · HG

Phase 3 trial of inosine for Parkinson's disease CCC

$5,170,824
Michael A Schwarzschild · Massachusetts General Hospital · U01 · FY2015 · NS

Atlanta Clinical and Translational Science Institute (ACTSI) Renewal

$5,168,749
David S Stephens · Emory University · UL1 · FY2014 · TR

Developing Antivirals Targeting Proteases and Polymerases of Coronaviruses, Picornaviruses and Bunyavirales

$5,168,269
Charles Scott Craik · University Of California, San Francisco · U19 · FY2022 · AI

Atlanta Clinical and Translational Science Institute (ACTSI) Renewal

$5,166,612
David S Stephens · Emory University · UL1 · FY2015 · TR

Comprehensive Cancer Center Core Support Grant

$5,163,099
Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2014 · CA

Center for Structural Biology of HIV RNA

$5,159,974
Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2025 · AI

Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS

$5,159,965
Neil Alan Shneider · Columbia University Health Sciences · U01 · FY2024 · NS

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT

$5,155,276
Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2021 · CA

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success

$5,151,440
Barry Coller · Rockefeller University · UL1 · FY2017 · TR